Skip to content

Effect of Qishen Huoxue Granules on coagulopathy/early DIC in sepsis and its mechanism

Effect of Qishen Huoxue Granules on coagulopathy/early DIC in sepsis and its mechanism

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044009
Enrollment
Unknown
Registered
2021-03-06
Start date
2021-03-06
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adults >= 18 years old, meet SEPSIS 3.0 diagnostic criteria and have coagulopathy/early DIC. 1) Sepsis inclusion criteria, according to SEPSIS 3.0 diagnostic criteria. 2) Coagulation disorders/early DIC, refer to the International Society of Thrombosis and Hemostasis DIC scoring system (ISTH) for diagnosis. DIC scores of 3 to 4 are included.

Exclusion criteria

Exclusion criteria: 1) Pregnant or breastfeeding women; 2) Aged 650 mg/d or warfarin in the past 7 days, or have undergone thrombolytic therapy in the past 1 month; 12) the patient is dying (estimated Died within 6 hours); 13) Known or suspected brain death; 14) Is undergoing dialysis treatment; 15) The patient is undergoing other treatment studies that may interfere with this study.

Design outcomes

Primary

MeasureTime frame
PT;D-Dimer;platelet;Fibrinogen;HMGB1;Thymidine phosphorylase;

Secondary

MeasureTime frame
Heparin binding protein;Alanine aminotransferase;Interleukin 10;Procalcitonin;AT III;Aspartate aminotransferase;Bilirubin;Creatinine;

Countries

China

Contacts

Public ContactQi Wenjie

Beijing Friendship Hospital, Capital Medical University

qwj02@126.com+86 13601318203

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026